Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Solvay seeks new indications for AndroGel

June 19, 2007

Diamyd Medical invalidates diabetes study

June 19, 2007

Canadian approval for Elaprase for Hunter's syndrome

June 19, 2007

Inhibition of aP2: a novel therapeutic strategy in treating diabetes and atherosclerosis

June 19, 2007

Recent Merck patent imparts novel antiobesity agents

June 19, 2007

Japanese launch for once-weekly Benet

June 18, 2007

FDA Advisory Committee recommends against approval of rimonabant

June 15, 2007

Elestrin launched in U.S.

June 15, 2007

Gabapentin GR begins phase II trial for menopausal hot flashes

June 15, 2007

Recent patents describe new treatment options for endocrine disorders

June 15, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...